Chemist + Druggist is part of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Pharmacy warned of synthetic opioids linked to increase in drug overdoses

Public Health England (PHE) has issued a National Patient Safety Alert following concerns around drug overdoses potentially linked to synthetic opioids.

The safety alert – which PHE asked NHS England and NHS Improvement to escalate to community pharmacy – contains urgent actions to be completed by tomorrow (August 20) by all organisations where staff may deal with people who use drugs.

 

A spike in the number of overdoses

 

According to the alert, in the past 10-14 days there have been an “unprecedented number of overdoses”, with some resulting in deaths, in people who use drugs – primarily heroin.

The cases have been registered in some parts of the country, including five London boroughs, Hampshire, Essex, West Sussex, Dorset and Thames Valley.

PHE is alerting those in contact with heroin users to the increased possibility of overdose, so they are “able to recognise possible symptoms of overdose and respond appropriately”.

Janice Perkins, chair of the Community Pharmacy Patient Safety Group, told C+D today (August 19) that the group will discuss this alert at its next meeting.

 

Plans to let pharmacists give naloxone

 

Earlier this month, the government announced that pharmacists and other professionals such as paramedics, nurses and police officers could be eligible to “hold and give” naloxone in a drive to tackle drug-related deaths.

The drug is used to reverse the effects of opioid overdoses. It is a prescription-only medicine and can currently be administered by anyone during an emergency.

However, only commissioned drug treatment services are currently able to “obtain and supply” naloxone without a prescription or another written authorisation, outside of an emergency.

Ms Perkins told C+D the group is “very supportive of the plans to facilitate take home naloxone as an important way of protecting lives”.

The decision to expand the use of naloxone to pharmacists and other healthcare professionals is subjected to an eight-week consultation, closing on 28 September.

Related Content

Topics



Pharmacy Dispenser/ Technician
Bethnal Green North, London
Salary: Up to £30,000

Apply Now
UsernamePublicRestriction

Register

CD135387

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel